ClinicalTrials.gg
RecruitingNCT05940714Updated Jul 11, 2023

Periodontopathogens of Periodontal Patients

An interventional study of Video participants in Periodontal Diseases, sponsored by University of Barcelona. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-11.

Sponsored by University of Barcelona · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2023, 3 years ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 26 studies in Periodontal Diseases with a site in Spain — 10 open to participants now, 10 under way, none of them phase 3. Periodontal Diseases · Spain.

Planned enrollment
4th of 18
50 · median 29
Started
2023
with 3 others
No phase
16 of 26
7 open now
Registered
13th of 26
by date
Lead sponsor
2 of 26
University of Barcelona

Among the 26 studies in Periodontal Diseases with a site in Spain, this one is the 4th largest by planned enrollment of the 18 interventional ones that give a count, is one of 4 that started in 2023, is one of 16 with no phase, and was the 13th registered.

Periodontal Diseases

871 studies on the registry are indexed under Periodontal Diseases; 191 are open to participants now.

Browse Periodontal Diseases studies →

Open to participants now

10 of the 26 studies in Periodontal Diseases with a site in Spain are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 102 Periodontal Diseases studies recruiting now, 48 (47%) set no upper age limit and 42 (41%) stop at 75 or younger; 5 take children under 18; 59 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Periodontal Diseases with a site in Spain, or all of them as a file.
02

Study summary

Study the presence of periodontal pathogens in a Catalan population with periodontitis and evaluate the influence of an intervention measure on oral hygiene teaching (video)

03

Conditions studied

  • Periodontal Diseases

Browse trials for

Keywords

  • periodontopathogens
  • oral hygiene
  • periodontal patients
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients over 18 years of age
  • periodontal disease (grade III and IV)
  • gave their to participate in the study
  • do not present associated medical pathology

Exclusion criteria

Exclusion Criteria:

  • Patients who do not wish to participate in the study
  • Patients following active treatment with antibiotics or having received antibiotic treatment in the last seven days,
  • Patients who wear braces.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Video participants

    Patients treated at the Hospital Odontològic Universitat de Barcelona (HOUB) who go for a routine visit in the period of the study and wish to participate. Parameters are measured and an oral hygiene teaching intervention is carried out.

    Behavioral: Video participants

  • No intervention
    Non video participants

    Patients treated at the Hospital Odontològic Universitat de Barcelona (HOUB) who go for a routine visit in the period of the study and wish to participate. Parameters are measured and and no initial intervention is performed.

Interventions

  • BehavioralVideo participants

    Showing a video of oral hygiene intructions

    Also known as: Study group

06

What researchers measure

Primary outcomes

  1. Presence of periodontopathogens

    Study the presence of periodontogens in a Catalan population with periodontitis and evaluate the influence of an intervention measure in the form of oral hygiene education.

    Time frame: 1 month

Secondary outcomes

  1. Correlate the microbiota and pro-inflammatory cytokine data obtained in the study population with the literature.

    Measure through conventional and molecular microbiological study of bacteria, looking for changes in the total count and measurement of cytokine through ELISA/cytometry test and search for quantitative changes

    Time frame: 1 month

  2. Determine if there are changes in the oral microbiota, before and after an intervention in the form of oral hygiene.

    Measure through conventional and molecular microbiological study of bacteria, looking for changes in the total count

    Time frame: 1 month

  3. Determine if there are changes in the levels of pro-inflammatory cytokines, before and after an intervention measure in the form of oral hygiene.

    Measurement through ELISA/cytometry test and search for quantitative changes

    Time frame: 1 month

  4. Correlate the level of periodontal disease with the patient's oral health.

    Classification established in the World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions

    Time frame: 1 month

  5. Correlate the level of periodontal disease with the patient's systemic diseases

    Classification established in the World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions and review of the clinical history

    Time frame: 1 month

  6. Correlate the variations in the oral microbiota with the patient's systemic diseases.

    Measure through conventional and molecular microbiological study of bacteria, looking for changes in the total count and review of the clinical history

    Time frame: 1 month

  7. Correlate variations in the levels of pro-inflammatory cytokines with the patient's systemic diseases.

    Measurement through ELISA/cytometry test and search for quantitative changes and review of the clinical history

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Nov 2023, 6 months after the start.

Of 314 non-industry interventional studies with no phase under Periodontal Diseases, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 28. This study's planned 6 months is below that.

Counting every sponsor, half of 333 studies reached it within 13 months; a quarter within 8 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2023
First posted
Jul 11, 2023
StartActual
May 15, 2023
Primary completionEst.
Nov 15, 2023
CompletionEst.
Oct 15, 2024
Last update
Jul 11, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05940714
Collaborators
Teresa Vinuesa Aumedes, Albert Estrugo Devesa, Felipe Aguilera Muñoz, Ester Fuste Domínguez, Enric Jané Salas, Isabel Martínez Lizán, Sonia Egido Moreno, Carlos Omaña Cepeda, Alexandra Merlos Gil
Responsible party
José López Lopez (doctor, University of Barcelona) — Principal investigator
First posted
Jul 11, 2023
Start date
May 15, 2023
Primary completion
Nov 15, 2023 (estimated)
Completion
Oct 15, 2024 (estimated)
Last update
Jul 11, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion